"45963-456-30" National Drug Code (NDC)

NDC Code	45963-456-30
Package Description	30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-456-30)
Product NDC	45963-456
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Deferasirox
Non-Proprietary Name	Deferasirox
Dosage Form	TABLET, FOR SUSPENSION
Usage	ORAL
Start Marketing Date	20190322
End Marketing Date	20260930
Marketing Category Name	ANDA
Application Number	ANDA203560
Manufacturer	Actavis Pharma, Inc.
Substance Name	DEFERASIROX
Strength	500
Strength Unit	mg/1
Pharmacy Classes	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]